StockNews.com Begins Coverage on Streamline Health Solutions (NASDAQ:STRM)

Analysts at StockNews.com started coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research note issued to investors on Tuesday. The firm set a “sell” rating on the stock.

Separately, Craig Hallum upgraded shares of Streamline Health Solutions to a “strong-buy” rating in a research note on Thursday, September 5th.

Streamline Health Solutions Price Performance

Shares of NASDAQ:STRM opened at $2.78 on Tuesday. The company’s fifty day moving average is $2.62 and its two-hundred day moving average is $5.36. The company has a market cap of $11.73 million, a P/E ratio of -0.58 and a beta of 1.64. Streamline Health Solutions has a 12-month low of $1.85 and a 12-month high of $9.75. The company has a quick ratio of 0.61, a current ratio of 0.61 and a debt-to-equity ratio of 0.66.

Streamline Health Solutions (NASDAQ:STRM) last announced its quarterly earnings data on Wednesday, September 11th. The company reported ($0.75) EPS for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.15). The business had revenue of $4.48 million for the quarter. Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.